Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: genetics

Why the human brain matures slower than its primate relatives

The human brain is a fascinating and complex organ that supports numerous sophisticated behaviors and abilities that are observed in no other animal species. For centuries, scientists have been trying to understand what is so unique about the human brain and how it develops over the human lifespan.

Recent technological and experimental advances have opened new avenues for neuroscience research, which in turn has led to the creation of increasingly detailed descriptions of the brain and its underlying processes. Collectively, these efforts are helping to shed new light on the underpinnings of various neuropsychiatric and neurodevelopmental disorders.

Researchers at Beijing Normal University, the Changping Laboratory and other institutes have recently set out to study both the human and macaque brain, comparing their development over time using various genetic and molecular analysis tools. Their paper, published in Nature Neuroscience, highlights some key differences between the two species, with the human pre-frontal cortex (PFC) developing slower than the macaque PFC.

Researchers Unveil a 4D Blueprint of the Human Genome

In a major step toward understanding how the physical form of DNA shapes human biology, researchers at Northwestern University working with the 4D Nucleome Project have created the most comprehensive maps yet of the genome’s three-dimensional organization over time and space. The work is described in a new study published in Nature.

The research, based on experiments in human embryonic stem cells and fibroblasts, provides an expansive picture of how genes interact with one another, fold into complex structures, and shift their positions as cells carry out normal functions and divide. The study was co-led by Feng Yue, the Duane and Susan Burnham Professor of Molecular Medicine in the Department of Biochemistry and Molecular Genetics.

“Understanding how the genome folds and reorganizes in three dimensions is essential to understanding how cells function,” said Yue, who is also director of the Center for Advanced Molecular Analysis and founding director of the Center for Cancer Genomics at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “These maps give us an unprecedented view of how genome structure helps regulate gene activity in space and time.”

Scientists May Have Discovered Why We Gained Consciousness

Of course, many people are familiar with the impressive mental abilities of the corvid family (crows, ravens, magpies, and jays), but even everyday avians like pigeons and chickens, would score surprisingly high on Newen and Montemayor’s consciousness scale. In one experiment known as the “mirror-audience test,” roosters were placed in an enclosure with a barrier separating them. When the shadow of a bird of prey was projected overhead, the test rooster warned its fellow conspecific (member of the same species), and when it was alone, it did not. Interestingly, when a mirror was placed in the enclosure to replace the previously see-through barrier, the test rooster did not warn its conspecific partner, even though the animal remained on the other side of the mirror, suggesting that the rooster was able to differentiate itself from other members of its own species.

“The presented results add to the growing body of evidence that consciousness may be present in many parts of the animal kingdom, across species that are phylogenetically distant from each other and have remarkably different brain structures,” the authors wrote. “Consciousness should not be deemed as an ‘all-or-nothing’ cognitive function but rather as a graded and multi-dimensional process.”

Preliminary Evidence for Increased Histone Succinylation as a Potential Epigenetic Marker for Longevity

Elevated histone succinylation distinguishes offspring of long-lived individuals and aligns with enhanced nuclear functions, while succinate supplementation selectively improves motor performance in…

The Virtual Cell Will Be More Like Gwas Than Alphafold

There has been significant discussion recently on the concept of the “virtual cell.” I want to summarize the key concepts regarding what the field wants from a virtual cell and the challenges we face. In particular, the current trajectory reminds me of the evolution of statistical genetics (GWAS) and Mendelian disorders—analogies that I believe point to the most likely path for the field’s development.

How an antiviral defense mechanism may lead to Alzheimer’s disease

One of the main proteins that contributes to Alzheimer’s disease is called phospho-tau (p-tau). When p-tau gets too many phosphate groups attached to it (a process called hyperphosphorylation), it starts to stick together and form clumps called “tangles” inside of brain nerve cells.

A new study by Mass General Brigham investigators shows that tau hyperphosphorylation may be a consequence of an antiviral response that protects the brain from infection. Results are published in Nature Neuroscience.

“As a geneticist, I always wondered why humans had evolved gene mutations predisposing to Alzheimer’s disease,” said senior author Rudolph Tanzi, Ph.D., Director of the McCance Center for Brain Health and Genetics and Aging Research Unit in the Mass General Brigham Department of Neurology.

Scientists grow mini brains to uncover cells behind autism-related brain overgrowth

A new study in the lab of Jason Stein, Ph.D., modeled brain development in a dish to identify cells and genes that influence infant brain growth, a trait associated with autism.

Researchers have made great strides to understand early signs of autism.

Studies have found that certain factors like genetics, sleep deprivation, excess fluid in the brain—and brain size—can increase the risk of neurodevelopmental conditions, like autism.

Single Injection Transforms the Immune System Into a Cancer-Killing Machine

Despite risks, results from both trials highlight the promise of one-and-done CAR T therapy for deadly blood cancers. But it’s still early days. Scientists need to carefully follow patients over years to understand how long upgraded T cells remain in the body and their effect on cancers.

And not all viral carriers are made the same. Lentiviruses, used in both studies, can tunnel into the human genome, causing DNA typos that potentially trigger secondary cancers. The durability of the therapy, its longevity, and immune side effects also need to be studied.

Kelonia is adding more patients to their trial, amid an increasingly competitive landscape. AstraZeneca has acquired EsoBiotec to bring its technology to market. AbbVie, a drug company in Illinois, is testing the delivery of gene-editing tools to T cells via fatty nanoparticles in clinical trials. And Kelonia is planning a second clinical trial with an initial 20 patients and 20 more in an expansion phase, none of whom responded to at least three previous treatments.

/* */